Phase
Condition
Circulation Disorders
Stress
Williams Syndrome
Treatment
Adempas (Riociguat, BAY63-2521)
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients diagnosed with Pulmonary Arterial Hypertension (PAH) participating orhaving participated in the Bayer-sponsored studies 12935, 16719 or 18588, who havecompleted the main study phase and are still being treated with riociguat (eitherwhile still being on treatment with the respective study drug or by commercial meanswith Adempas) and who, in the opinion of the investigator, are expected to continueto have an overall positive benefit/risk from continuing treatment.
Women and men of reproductive potential must agree to use adequate contraceptionwhen sexually active. This applies for the time period between signing of theinformed consent form and 30 days after the last administration of study drug.
Exclusion
Exclusion Criteria:
Ongoing serious adverse event (SAE) from originating study that is assessed asrelated to riociguat
Pregnant women or breast-feeding women
Any contra-indication to Adempas treatment listed in the BAY63-2521 / RiociguatInvestigators's Brochure
Concomitant participation in another clinical study with the study drug
Patients with pulmonary hypertension associated with idiopathic interstitialpneumonia (PH-IIP)
Study Design
Connect with a study center
empty
Besancon, 25030
FranceSite Not Available
Besancon, 25030
FranceCompleted
Besançon 3033123, 25030
FranceSite Not Available
empty
Brest, F-29609
FranceSite Not Available
Brest, F-29609
FranceCompleted
Brest 3030300, F-29609
FranceSite Not Available
empty
Le Kremlin Bicetre Cedex, 94275
FranceSite Not Available
Le Kremlin Bicetre Cedex, 94275
FranceCompleted
Le Kremlin-Bicêtre 3003737, 94275
FranceSite Not Available
empty
Le Kremlin-bicetre, 94275
FranceSite Not Available
Lille 2998324, 59037
FranceSite Not Available
empty
Lille Cedex, 59037
FranceSite Not Available
Lille Cedex, 59037
FranceCompleted
empty
Rouen, 76031
FranceSite Not Available
Rouen, 76031
FranceCompleted
Rouen 2982652, 76031
FranceSite Not Available
empty
Roma, Lazio 00161
ItalySite Not Available
Roma, Lazio 00161
ItalySite Not Available
empty
Pavia, Lombardia 27100
ItalySite Not Available
Pavia, Lombardia 27100
ItalySite Not Available
empty
Seoul, 6351
Korea, Republic ofSite Not Available
Seoul, 03722
Korea, Republic ofActive - Recruiting
empty
Krakow, 31-202
PolandSite Not Available
Krakow, 31-202
PolandSite Not Available
empty
Lodz, 91-347
PolandSite Not Available
Lodz, 91-347
PolandSite Not Available
empty
Otwock, 05-400
PolandSite Not Available
Otwock, 05-400
PolandSite Not Available
empty
Wroclaw, 51-124
PolandSite Not Available
Wroclaw, 51-124
PolandSite Not Available
Seoul 1835848, Seoul Teugbyeolsi 05505
South KoreaSite Not Available
empty
Bangkok, 10330
ThailandSite Not Available
Bangkok, 10330
ThailandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.